360 filings
Page 7 of 18
8-K
zgt rs3o89w9mg
4 Jun 21
Submission of Matters to a Vote of Security Holders
5:00pm
4
s4h0pxnhh
24 May 21
PhaseBio Pharmaceuticals / John P Sharp ownership change
6:11pm
4
ksqs3y8 sfckf9
24 May 21
PhaseBio Pharmaceuticals / Glen Burkhardt ownership change
6:11pm
4
0cuvy7
24 May 21
PhaseBio Pharmaceuticals / Jonathan P Mow ownership change
6:10pm
4
z4ogpmiionco us1k
24 May 21
PhaseBio Pharmaceuticals / Michael York ownership change
6:10pm
4
uznh0fap28rm67wyjsdf
24 May 21
PhaseBio Pharmaceuticals / Susan Elizabeth Arnold ownership change
6:09pm
4
vpe5vk8
24 May 21
PhaseBio Pharmaceuticals / Kristopher Hanson ownership change
6:09pm
SC 13G
s5h0u5m0t9l
19 May 21
PhaseBio Pharmaceuticals / Rosalind Advisors ownership change
2:25pm
8-K
u77c9
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
SC 13G
ucvwd6ilx7q8w1h
24 Mar 21
PhaseBio Pharmaceuticals / RA CAPITAL MANAGEMENT ownership change
4:30pm
SC 13G
puc2zbowvgjc
22 Mar 21
PhaseBio Pharmaceuticals / Avidity Partners Management ownership change
4:05pm
8-K
ajq 8do1kgvvntd
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
424B5
g1pze1bj 92h
19 Mar 21
Prospectus supplement for primary offering
4:04pm
424B5
2ycly7
17 Mar 21
Prospectus supplement for primary offering
5:07pm
S-8
u6dlv0avjdz 5cjbus
15 Mar 21
Registration of securities for employees
8:42am
8-K
8fmh3my
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am
8-K
sjn9cg12iluerby47kg
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am